Skip to content

Effect of Oral Passiflora Incarnata on cough during extubation

Effect of preoperative oral Passiflora Incarnata on cough during extubation in Ambulatory Surgery Patients: A Double Blind, Placebo Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301075140N8
Enrollment
120
Registered
2014-11-23
Start date
2014-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other and unspecified abnormalities of breathing. unspecified abnormalities of breathing

Interventions

Placebo , orally, 120 min before surgery
Intervention 1: Passiflora incarnata, 500 mg, ( PassipyTM IranDarouk) orally 120 min before surgery. Intervention 2: Placebo , orally, 120 min before surgery.
Treatment - Drugs

Sponsors

Vice chancellor of research-Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients referring to our anesthesia clinic, classified as American Society of Anesthesiologists (ASA) physical status of I or II, aged 18-60, who will be candidated for ambulatory inguinal herniorhaphy. Exclusion criteria: Patients with a history of anxiety disorders or consuming sedative, analgesic, antidepressant, or antiepileptic drugs; addict patients; patients with numerical rating scale (NRS) of less than one, for anxiety; Patients with any contraindications to the medications of study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cough. Timepoint: cough after tracheal extubation. Method of measurement: Observation.

Secondary

MeasureTime frame
Psychomotor function. Timepoint: at arrival in the operating room, and 90 min after tracheal extubation. Method of measurement: assessed with the Trieger Dot Test (TDT) and the Digit-Symbol Substitution Test (DSST).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Omid Azimaraghi

Chief Resident of Anesthesiology , Dr Shariati Hospital

o.azimaraghi@gmail.com+98 21 2206 6194

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026